Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID-19 severe respiratory failure (MUST COVID): A retrospective cohort study.
Barrett CD, Moore HB, Moore EE, Benjamin Christie D 3rd, Orfanos S, Anez-Bustillos L, Jhunjhunwala R, Hussain S, Shaefi S, Wang J, Hajizadeh N, Baedorf-Kassis EN, Al-Shammaa A, Capers K, Banner-Goodspeed V, Wright FL, Bull T, Moore PK, Nemec H, Thomas Buchanan J, Nonnemacher C, Rajcooar N, Ramdeo R, Yacoub M, Guevara A, Espinal A, Hattar L, Moraco A, McIntyre R, Talmor DS, Sauaia A, Yaffe MB. Barrett CD, et al. Among authors: moore pk. Res Pract Thromb Haemost. 2022 Mar 21;6(2):e12669. doi: 10.1002/rth2.12669. eCollection 2022 Feb. Res Pract Thromb Haemost. 2022. PMID: 35341072 Free PMC article.
Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?
Moore HB, Barrett CD, Moore EE, McIntyre RC, Moore PK, Talmor DS, Moore FA, Yaffe MB. Moore HB, et al. Among authors: moore ee, moore pk, moore fa. J Trauma Acute Care Surg. 2020 Jun;88(6):713-714. doi: 10.1097/TA.0000000000002694. J Trauma Acute Care Surg. 2020. PMID: 32281766 Free PMC article. No abstract available.
Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis.
Choudhury R, Barrett CD, Moore HB, Moore EE, McIntyre RC, Moore PK, Talmor DS, Nydam TL, Yaffe MB. Choudhury R, et al. Among authors: moore ee, moore hb, moore pk. World J Emerg Surg. 2020 Apr 20;15(1):29. doi: 10.1186/s13017-020-00305-4. World J Emerg Surg. 2020. PMID: 32312290 Free PMC article.
Fibrinolytic therapy for refractory COVID-19 acute respiratory distress syndrome: Scientific rationale and review.
Barrett CD, Moore HB, Moore EE, McIntyre RC, Moore PK, Burke J, Hua F, Apgar J, Talmor DS, Sauaia A, Liptzin DR, Veress LA, Yaffe MB. Barrett CD, et al. Among authors: moore ee, moore hb, moore pk. Res Pract Thromb Haemost. 2020 Jun 12;4(4):524-531. doi: 10.1002/rth2.12357. eCollection 2020 May. Res Pract Thromb Haemost. 2020. PMID: 32542213 Free PMC article. Review.
239 results